Cardiac Science to Present at the Roth Capital Partners 20th Annual Growth Stock Conference |
(Archive News Story - Products mentioned in this Archive News Story may or may not be available from the manufacturer.)
Cardiac Science Inc.
3303 Monte Villa Pkwy.
Everett, WA, 98201
USA
Press release date: February 13, 2008
BOTHELL, Wash., Feb. 13 -- Cardiac Science Corporation (NASDAQ:CSCX), a global leader in advanced cardiac diagnosis, resuscitation, rehabilitation, and informatics products, announced today that it will present at the Roth Capital Partners 20th Annual OC Growth Stock Conference on Wednesday, February 20, 2008 at the Ritz Carlton Laguna Nigel. Mike Matysik, the company's senior vice president and chief financial officer, will present the Company's business strategy and third quarter financial results at 8:30 a.m. Pacific Time.
Attendance at the conference is by invitation only. Cardiac Science will offer a live audio webcast of its presentation, which may be accessed at the Company's website at http://www.cardiacscience.com/. An archived replay of the presentation will also be available following the live presentation and can be accessed at http://www.cardiacscience.com/.
About Cardiac Science Corporation
Cardiac Science develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including AEDs, electrocardiographs, stress test systems, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The Company sells a variety of related products and consumables, and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick®, HeartCentrix®, Powerheart®, and Quinton® brands, is headquartered in Bothell, Washington. With customers in more than 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425-402-2000 or visit http://www.cardiacscience.com/.
Company Contact: Mike Matysik Cardiac Science Corporation Sr. Vice President and CFO (425) 402-2009
Investor Contact: Doug Sherk/Jenifer Kirtland EVC Group, Inc. (415) 896-6820
Media Contact: Christopher Gale EVC Group, Inc. (201) 646-5431 (203) 570-4681 cgale@evcgroup.com
Source: Cardiac Science Corporation
Web site: http://www.cardiacscience.com/
|
|
|
|
|
|
| 
